脓毒症相关急性肾损伤的治疗标准
本文综述脓毒症相关急性肾损伤(SA-AKI)的当前治疗标准,并讨论其病理生理、诊断、结局预测和管理的新进展。脓毒症占危重成人患者所有AKI的约50%,SA-AKI与发病率和死亡率增加相关。尽管在检测、预防和治疗方面取得进展,SA-AKI仍是危重临床状况和主要健康负担,需进一步研究以减轻其短期和长期后果。
要点
- 脓毒症占危重成人患者所有急性肾损伤的约50%。
- SA-AKI是最常见的器官功能障碍,与发病率和死亡率增加相关。
- 综述涵盖SA-AKI当前治疗标准及病理生理、诊断、结局预测和管理新进展。
核心结论
- SA-AKI仍是危重临床状况和主要健康负担,需进一步研究以减轻其短期和长期后果。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 脓毒症占危重成人患者所有急性肾损伤的约50%。
- SA-AKI是最常见的器官功能障碍,与发病率和死亡率增加相关。
- 不断增长的证据揭示了临床危险因素、病理生物学、治疗反应和肾脏恢复要素的关键方面,提升了检测、预防和治疗SA-AKI的能力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sepsis is a host's deleterious response to infection, which could lead to life-threatening organ dysfunction. Sepsis-associated acute kidney injury (SA-AKI) is the most frequent organ dysfunction and is associated with increased morbidity and mortality. Sepsis contributes to ≈50% of all AKI in critically ill adult patients. A growing body of evidence has unveiled key aspects of the clinical risk factors, pathobiology, response to treatment and elements of renal recovery that have advanced our ability to detect, prevent and treat SA-AKI. Despite these advancements, SA-AKI remains a critical clinical condition and a major health burden, and further studies are needed to diminish the short and long-term consequences of SA-AKI. We review the current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management of SA-AKI.
引用
- Zarbock A, Koyner JL, Gomez H, et al. Sepsis-associated acute kidney injury-treatment standard. Nephrol Dial Transplant. 2023. PMID: 37401137. doi:10.1093/ndt/gfad142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。